Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

[Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk].

Martínez Castelao A.

Nefrologia. 2008;28 Suppl 5:79-84. Review. Spanish.

PMID:
18847425
[PubMed - indexed for MEDLINE]
2.

Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Coccheri S.

Drugs. 2007;67(7):997-1026. Review.

PMID:
17488145
[PubMed - indexed for MEDLINE]
3.

The rough road for rosiglitazone.

Goldfine AB.

Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):113-7. doi: 10.1097/MED.0b013e3282f8b483. Review.

PMID:
18316944
[PubMed - indexed for MEDLINE]
4.

Glitazones in chronic kidney disease: potential and concerns.

Bolignano D, Zoccali C.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):167-75. doi: 10.1016/j.numecd.2011.11.005. Epub 2012 Feb 23. Review. Erratum in: Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):75.

PMID:
22364889
[PubMed - indexed for MEDLINE]
5.

Diabetic nephropathy, chronic kidney disease and metabolic syndrome in Type 2 diabetes: answers or more questions?

Senior PA.

Diabet Med. 2008 Dec;25(12):1377-9. doi: 10.1111/j.1464-5491.2008.02624.x. No abstract available.

PMID:
19046234
[PubMed - indexed for MEDLINE]
6.

Thiazolidinediones and diabetic nephropathy: need for a closer examination?

Sarafidis PA.

J Cardiometab Syndr. 2007 Fall;2(4):297-301. Review.

PMID:
18059215
[PubMed - indexed for MEDLINE]
7.

Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.

Scuteri A, Najjar SS, Orru' M, Albai G, Strait J, Tarasov KV, Piras MG, Cao A, Schlessinger D, Uda M, Lakatta EG.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):532-41. doi: 10.1016/j.numecd.2008.11.004. Epub 2009 Mar 25.

PMID:
19321325
[PubMed - indexed for MEDLINE]
8.

Improving microvascular outcomes in patients with diabetes through management of hypertension.

McGill JB.

Postgrad Med. 2009 Mar;121(2):89-101. doi: 10.3810/pgm.2009.03.1980. Review.

PMID:
19332966
[PubMed - indexed for MEDLINE]
9.

[Practical management of oral antidiabetics in patients with renal disease].

Alcazar R, Gonzalez Albarran O, Honorato J, Robles NR, Acha J, de Alvaro F, Fernandez Gallego V, Gomez Garcia P, Lopez de la Torre M, Martinez Castelao A, Romero R.

Nefrologia. 2006;26(5):538-58. Review. Spanish. No abstract available.

PMID:
17117897
[PubMed - indexed for MEDLINE]
Free Article
10.

Traditional cardiac risk factors in individuals with chronic kidney disease.

Uhlig K, Levey AS, Sarnak MJ.

Semin Dial. 2003 Mar-Apr;16(2):118-27. Review.

PMID:
12641876
[PubMed - indexed for MEDLINE]
11.

Concomitant macro and microvascular complications in diabetic nephropathy.

Alwakeel JS, Al-Suwaida A, Isnani AC, Al-Harbi A, Alam A.

Saudi J Kidney Dis Transpl. 2009 May;20(3):402-9.

PMID:
19414942
[PubMed - indexed for MEDLINE]
Free Article
12.

Rosiglitazone and cardiovascular risk: weighing recent evidence.

Stafylas PC, Sarafidis PA, Lasaridis AN.

J Cardiometab Syndr. 2007 Fall;2(4):295-6. Review. No abstract available.

PMID:
18059214
[PubMed - indexed for MEDLINE]
13.

Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.

Krentz A.

Diabetes Metab Res Rev. 2009 Feb;25(2):112-26. doi: 10.1002/dmrr.937. Review.

PMID:
19219860
[PubMed - indexed for MEDLINE]
14.

Role of renin-angiotensin system blockade in patients with diabetes mellitus.

Braga MF, Leiter LA.

Am J Cardiol. 2009 Sep 15;104(6):835-9. doi: 10.1016/j.amjcard.2009.05.015. Review.

PMID:
19733720
[PubMed - indexed for MEDLINE]
15.

The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.

Andreadis EA, Katsanou PM, Georgiopoulos DX, Tsourous GI, Yfanti GK, Gouveri ET, Diamantopoulos EJ.

Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):175-80. doi: 10.1055/s-0028-1087177. Epub 2008 Dec 3.

PMID:
19053032
[PubMed - indexed for MEDLINE]
16.

Renal protection in diabetes: role of glycemic control.

Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, Mussap M.

J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S86-9. Review.

PMID:
16565255
[PubMed - indexed for MEDLINE]
Free Article
17.

Epidemiology of the diabetic heart.

Tziakas DN, Chalikias GK, Kaski JC.

Coron Artery Dis. 2005 Nov;16 Suppl 1:S3-S10. Review.

PMID:
16340402
[PubMed - indexed for MEDLINE]
18.

Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy.

Gross ML, Dikow R, Ritz E.

Kidney Int Suppl. 2005 Apr;(94):S50-3. Review. Erratum in: Kidney Int Suppl. 2005 Jul;68(1):427.

PMID:
15752240
[PubMed - indexed for MEDLINE]
Free Article
19.

Nutrition interventions for prevention of type 2 diabetes and the metabolic syndrome.

Pittas AG.

Nutr Clin Care. 2003 May-Sep;6(2):79-88. Review.

PMID:
14692296
[PubMed - indexed for MEDLINE]
20.

Twelve shifting paradigms in diabetic renal disease and hypertension.

Mogensen CE.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S2-9. doi: 10.1016/j.diabres.2008.09.029. Epub 2008 Oct 23.

PMID:
18947897
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk